GRAS ESCARDO, JORDI,LLENAS CALVO, JESUS,RYDER, HAMISH,ORVIZ DIAZ, PIO
申请号：
DK10010080
公开号：
DK2292267T3
申请日:
2005.05.31
申请国别(地区):
DK
年份:
2014
代理人:
摘要：
Combination (I) comprises a phosphodiesterase inhibitor 4 (PDE4) (A) and an antagonist of M3 muscarinic receptors (B) (3(R)-(2-hydroxy-2, 2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo [2.2.2] octane), in the form of a salt having an anion X (anion of a mono or polyvalent acid). An independent claim is also included for a method of treating a patient suffering from or susceptible to a respiratory disease or condition which responds to M3 antagonism comprising simultaneous, concurrent, separate or sequential administration of (I). ACTIVITY : Antiasthmatic； Respiratory-Gen.； Antiinflammatory. MECHANISM OF ACTION : Phosphodiesterase-4 inhibitor； Muscarinic receptors antagonist； Leukotriene-D4 antagonist； Neurokinin-1- receptor antagonist； Epidermal growth factor receptor kinase inhibitor； Beta-2 agonist； p38 Kinase inhibitor.
